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Abstract
A large amount of research has been devoted to the detection and investigation
of epistatic interactions in genome-wide association studies (GWASs). Most of
the literature focuses on low-order interactions between single-nucleotide poly-
morphisms (SNPs) with significant main effects.
In this paper we propose an original approach for detecting epistasis at the
gene level, without systematically filtering on significant genes. We first compute
interaction variables for each gene pair by finding its Eigen-Epistasis component,
defined as the linear combination of Gene SNPs having the highest correlation
with the phenotype. The selection of significant effects is done using a penalized
regression method based on Group Lasso controlling the False Discovery Rate.
The method is tested against two recent alternative proposals from the lit-
erature using synthetic data, and shows good performances in different settings.
We demonstrate the power of our approach by detecting new gene-gene inter-
actions on three genome-wide association studies.
Key words : Genome-wide association study, Gene-gene interactions, Epis-
tasis, Group Lasso
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Background
Genome Wide Association Studies (GWASs) look for genetic markers linked to
a phenotype of interest. Typically, hundreds of thousands of single nucleotide
polymorphisms (SNPs) are studied for a limited number of individuals using
high-density genotyping arrays. Usually the association between each SNP and
the phenotype is tested using single-marker methods. Multiple markers may also
be considered, but these are typically selected using simple forward-selection
methods. GWASs are a powerful tool for investigating the genetic architecture
of complex diseases and have been successful in identifying hundreds of vari-
ants. However, they have been able to explain only a small proportion of the
phenotypic variations expected from classical family studies [1]. A number of
explanations for this missing heritability have been put forward. For example, it
has been suggested that shared environments among relatives are not adequately
taken into account. Another suggestion is that much larger numbers of variants
with small effects remain to be identified. Rare variants, which are difficult to
find using existing genotyping arrays [1], seem to be important causal factors,
and so do structural variations. But complex diseases may also be caused, at
least in part, by complex genetic structures with multiple interactions between
markers (a phenomenon termed epistasis). Whereas in pedigree studies the
genetic effect on phenotype is seen as part of the additive genetic variance, in
GWASs it is seen as an unmeasured interaction between genes [2]. For example,
Zuk et al. proposed a model that takes into account epistatic interaction in
relation to Crohn’s disease [3]. They found that 80% of the missing heritability
could be due to genetic interactions.
In recent years a number of methods for studying epistasis have been pro-
posed and reported in various reviews [4, 5, 6]. They vary in terms of their data
analysis (genome-wide or filtering) and their statistical methodology (Bayesian,
frequentist, machine learning or data mining). Most of them focus on single-
locus interactions, but considering interactions at the gene level can have several
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advantages. First, given that genes are the functional unit of the genome, re-
sults may be more biologically interpretable. Second, genetic effects are more
easily detected when SNP effects are aggregated together. Third, gene-based
analysis simplifies the multiple testing problem by reducing the number of vari-
ables. Several gene-gene methods have been proposed. These are based on a
summarizing step which is used to obtain information at the gene level. In more
recent methods, filters or penalized models are used to make the method ap-
plicable to a large number of genes, while older methods are only applicable to
two or a very limited number of genes. For the summarizing step, most meth-
ods resort to a principal components (PC) approach, but each method has its
specific characteristics. We describe some of these below.
Chatterjee et al. harnessed Tukey’s one-degree-of-freedom method to investi-
gate interaction between two genes [7]. Their method is based on the assumption
that the SNPs included in each gene region act as surrogates for an underlying
biological phenotype. The genotypic information for the gene region is extracted
as a single component by a weighted sum of all SNPs. The weights are deter-
mined according to the SNP’s correlation with the trait. The product of the two
sums is then introduced as the gene-gene interaction term into a logistic model,
where marginal effects are represented by the respective sums. Building on this
idea, Wang et al. compared two different interaction tests [8]. On the one hand,
they used Principal Component Analysis (PCA) to summarize SNP information
within a gene, and on the other hand they used Partial Least Squares (PLS)
to extract components that summarize, first, the information among SNPs in
a gene and, second, the correlation between SNPs and the outcome of interest.
They then proposed an interaction test based on either the first PC or the first
PLS component for each gene, and were able to show that the PCA and PLS
methods often outperformed Tukey’s one-degree-of-freedom method. But it is
worth noting that the main objective of these three methods was improving the
detection of associations in the presence of gene-gene interactions, rather than
identifying the interactions themselves. Other approaches based on principal
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component analysis have since been proposed for epistasis detection. Li et al.
proposed selecting, as the gene representation, PCs that are able to explain at
least 80% of the variation [9].
Genotypic data are characterized by the high correlation among markers
resulting from so-called linkage disequilibrium (LD). Procedures that take LD
information into account have been developed for epistasis detection. For exam-
ple, He et al. proposed an approach using LD information to weight genotype
scores which are then aggregated using principal components [10]. Rajapakse
et al. developed a gene-based test of interactions for case-control studies which
compares LD patterns between cases and controls [11]. Using the same idea,
Peng et al. used a canonical correlation-based U-statistic model (CCU) to de-
tect co-association in case-control studies [12]. The idea is to test for two given
genes the difference between canonical correlation coefficient computed by CCA
among cases and among controls. Their work was subsequently extended to
include kernel [13, 14].
However most of these methods can be applied only to a reduced number of
genes. Computational constraints mean that it is not feasible to model all gene-
gene interactions directly. One way of overcoming this is to reduce the gene-gene
search space by eliminating unimportant genes, and to this end two-step proce-
dures have been developed that first filter out specific genes or SNPs through a
genome-wide search before testing for interactions. One example of this is the
model-based kernel machine method (3G-SPA) proposed by Li and Cui, which
first performs a search for gene pairs contributing to the overall phenotypic
variations [15]. Significant pairs are then tested for interaction effects. Another
attractive alternative is offered by penalized regression methods that select a
subset of important predictors out of a large number of potential predictors.
These methods operate by shrinking the size of the coefficients. The coefficients
of predictors with little or no apparent effect are force to be set to zero, reducing
the effective degrees of freedom and in many cases making model selection possi-
ble. A few approaches using penalized models have been proposed. D’Angelo et
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al. combined principal component analysis and lasso penalized regression [16].
Wang et al. used a principal component analysis combined with an L1 penalty,
with adaptive weights based on gene size, pathway support and effect size [17].
Here we propose a Group Lasso approach [18] that takes into account the
group structure of each gene in order to detect epistasis. We introduce Gene-
Gene Eigen-Epistasis (G-GEE) as a new approach for computing the gene-
gene interaction part of the model, and we compare G-GEE with two different
interaction variable modeling approaches inspired by previous proposals in the
literature, namely PCA and PLS. An adaptive ridge-cleaning approach [19] is
then used in order to compute p-values for each group.
In the next section, we detail each model and outline the design of the simula-
tion studies performed to compare the performance of the different approaches.
In the Results section, the findings of the simulation studies are shown, and we
illustrate our approach on three real datasets relating to ankylosing spondylitis,
thyroid carcinomas and inflammatory bowel disease. The different approaches
and the results are discussed in the last section.
Methods
We consider n individuals where y = (y1, y2, ..., yn)T denotes the vector of trait
values. For each individual, genetic variants among G genes are considered.
Each gene is described by a given number of SNPs pg where
∑
g pg = p. The SNP
matrix X ∈ Rn×p considers an additive coding scheme in which the genotype
value of each SNP j from individual i is denoted Xij ∈ {1, 2, 3}. Xi is a p-
dimensional vector of covariates for observation i and for j ∈ {1, . . . , p}. Xg
denotes the submatrix of X whose columns are the pg SNPs of gene g. A
generalized linear model is generally assumed for GWAS, where the phenotype
is considered as a random variable yi whose conditional expectation can be
written as a function of the covariates Xi and their interactions Zi,
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g(E[yi|X]) = XTi β +ZTi γ,
where
β =
β1,1, β1,2, ..., β1,p1︸ ︷︷ ︸
gene1
, ..., βG,1, ..., βG,pG︸ ︷︷ ︸
geneG

T
,
and Zi is the ith line of the matrix of interactions and γ a parameter vector
of appropriate dimension. When the phenotype is binary (case control study),
it is usual to assume a logistic model where g() is the logit and Y is assumed
to follow a binomial distribution. Below we will consider only quantitative
phenotypes using a classical linear model. In this case g() is the identity and
the residuals are assumed to be Gaussian.
The main effect of each gene is modeled through the sum of the effects of all
its SNPs. Concerning interaction effects, we compute new variables representing
interactions between two specific genes and define as a group all the interaction
variables related to a given pair of genes. The matrix of interaction is thus
structured into G(G− 1)/2 submatrices:
Z = [Z11 · · ·Zrs · · ·ZG(G−1)/2]
where Zrs describes the interactions between the two genes r and s. The
parameter vector γ is accordingly structured into sub-vectors γrs. We will
now present and compare three different approaches for modeling gene-gene
interactions.
Modeling Gene-Gene interactions
Let us consider two genes r and s described respectively by pr and ps SNPs. A
possible interaction term describing the epistasis between the two genes is
Zrsi
Tγrs =
pr∑
j=1
ps∑
k=1
γrsjkX
r
ijX
s
ik. (1)
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We hereafter setW rs = {XrijXsik}j=1,··· ,pr;k=1,··· ,psi=1···n . In this case the subma-
trix of interactions is Zrs = W rs and γrs = {γrsjk} is a vector of size prps. The
number of parameters in such a model is obviously too large to be reliably es-
timated. For this reason a number of papers in the literature consider reducing
the dimension of γ.
In this paper we will consider three different methods for reducing the di-
mension reduction, namely Principal Component Analysis (PCA), Partial Least
Squares (PLS), and our proposed Gene-Gene Eigen-Epistasis approach that we
have termed G-GEE.
Principal Component Analysis
Principal Component Analysis (PCA) can reduce the number of variables de-
scribing each gene r from pr to qr < pr. Considering gene r described by pr
SNPs, we compute the matrix of the first q principal components
Cr = XrUr,
where Ur is the matrix of the first qr principal axes. Using Cr and Cs instead
of Xr and Xs in the computation of the interaction allows the number of
parameters relative to each interaction to be controlled. This control is achieved
by choosing the number of principal components q. The PCA model that we
describe draws upon ideas in [20]. The interaction term takes the form
Zrsi
Tγrs =
q∑
j=1
q∑
k=1
γrsjkC
r
ijC
s
ik.
Relating this expression to the general form of the interaction term W rsi
described above, we can see that performing PCA prior to computing the in-
teractions is a means of constraining the linear interaction term of Equation
1.
The submatrix of interactions is Zrs = {CrijCsik}j=1,··· ,q;k=1,··· ,qi=1···n , and γrs =
{γrsjk} is a vector of size q2 describing the interaction between genes r and s.
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In particular, if a single principal component is chosen, there will be only one
parameter to estimate per interaction.
Partial Least Squares
Wang et al. proposed an alternative method for integrating interactions us-
ing a PLS approach [8]. Let (Xr,Xs) be the genotypic matrix for the given
pair of genes (r, s). Their approach computes the components that maximize
cov2(Xru,Tv), with T = (y,Xs) and (u,v) the weight vectors. The interac-
tion of a couple of genes (r, s) is then represented by the first q components:
Zrsi
Tγrs =
q∑
j=1
γrsj T
rs
ij .
In this approach phenotypic information is retained when the interaction
variables are constructed.
Gene-Gene Eigen-Epistasis
We propose an original approach for modeling interactions. The general idea is
to consider the interaction variable between the two genes r and s as a function
fu(X
r,Xs) parameterized by u. One way to estimate u is to maximize the
correlation between the interaction function and the phenotype:
uˆ = arg max
u,‖u‖=1
cov2(y, fu(X
r,Xs)).
If we consider the function f to be linear, our problem becomes easily tractable
and has only one solution. Setting
Zrs = fu(X
r,Xs) = W rsu,
whereW rs = {XrijXsik}j=1··· ,pr;k=1,··· ,psi=1···n and u ∈ Rprps we obtain the following
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problem:
max
u,‖u‖=1
|| ˆcov[W rsu,y]||2 = max
u,‖u‖=1
||uTW rsTy||2 = max
u,‖u‖=1
uTW rsTyyTW rsu .
(2)
The solution u is the eigenvector corresponding to the largest eigenvalue
of the matrix W rsTyyTW rs, which is the vector W rsTy. The complexity
of computing u is therefore in O(nprps). We then use the projection of the
matrix W rs on u as the interaction variable. The resulting Eigen-Epistasis
vector Z is the linear combination of all the SNP-SNP interactions being the
most correlated with the phenotype. In its construction, G-GEE has similarities
with PLS. The main difference lies in the original design matrix. PLS searches
for components that maximize cov2(Xru,yXsv), whereas G-GEE retains the
component that maximizes cov2(y,W rsu), withW rs the matrix of all pairwise
interaction between the two genes r and s. Like PLS, G-GEE takes phenotypic
information into account in the construction of the interaction variables. Other
methods as such as CCU [12] and the kernel versions of CCU [13, 14] that we
referred to in the introduction also consider the phenotype in their construction,
but these methods can be applied only to case-control problems.
Estimation of coefficients
We propose a Group Lasso approach [18] for estimating the parameters of linear
or logistic (case control) regression. A group comprises either the SNPs of a
given gene, or interaction terms relative to a given gene-pair interaction. In the
particular case of linear regression, the model parameters are estimated by:
θˆ = (βˆ, γˆ) = argmin
β,γ
(∑
i
(yi −Xiβ −Ziγ)2 + λ
[∑
g
√
pg||βg||2 +
∑
rs
√
prps||γrs||2
])
,
The parameter λ is selected by cross-validation.
In order to improve estimation accuracy and to obtain p-values for each
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of the selected groups, we use the adaptive ridge cleaning approach proposed
by Bécu et al. [19]. This screen and clean procedure is a two-stage method.
The group lasso model is first fitted on half of the data. The coefficient of
the candidate groups selected by the model are then introduced into a ridge
regression model fitted on the second half of the data with a specific penalty
that allows the group structure to be taken into account. For each group the
significance of the regression coefficients is estimated using permutation tests.
Simulation Design
To evaluate the performance of the proposed approach, we conducted two simu-
lation studies, the first using simulated data and the second using a real dataset
relating to ankylosing spondylitis. In each case we compared the proposed G-
GEE model to the two other interaction variable modeling approaches. The
first simulation corresponds to a simplified context where all parameters were
controlled and external interference limited, while the second simulation corre-
sponds to a realistic context with a realistic pattern of MAF and LD.
Design
Genotypes Our first (simplified) simulation study was adapted from the
model used in [21] with an extension to control the minor allele frequency (MAF)
of each SNP. The n lines of the genotype matrix are an i.i.d. sample from a
multivariate random vector Xi ∼ Np(0,Σ). The correlation matrix Σ is block
diagonal, each block corresponding to a gene. Two variables belonging to the
same gene are correlated at level ρ = 0.8 while all other correlations are null.
Each SNP (column of the genotype matrix) is randomly assigned an MAF p from
a uniform distribution between 0.05 and 0.5. An MAF value of 0.2 is assigned
to all causal SNPs. The genotype frequencies derived from the Hardy-Weinberg
equation are then used to discretize Xik values to 1, 2 or 3. In practice, Xik is
set to 1 if Xik < qp2;N(0,1), Xik is set to 3 if Xik < q(1−p)2;N(0,1) and Xik is set
to 2 otherwise.
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In the second (realistic) simulation study using a real ankylosing spondylitis
dataset, genes are randomly selected. The number of SNPs composing each
genes varies according to the selection.
Phenotypes For both simulation studies, we generated phenotype vectors
using two different schemes. Our first scheme corresponds to the model proposed
by Wang et al. [17] (which, for the sake of brevity, we will refer to hereafter as
the “Wang Pathway” model):
Yi = β0 +
∑
g
βg
(∑
k∈C
Xgik
)
+
∑
rs
γrs
 ∑
(j,k)∈C2
XrijX
s
ik
+ i, (3)
where C and C2 are respectively the set of causal SNPs and causal interac-
tions, and i a random Gaussian variable. For each causal gene g, we consider
two causal SNPs and a coefficient βg is assigned to the standardized sum of
these causal SNPs. In the same way, for the interactions, all the causal SNPs
from a causal pair (r, s) are pairwise multiplied and a coefficient γrs is assigned
to the standardized sum of the product.
Our second scheme for simulating phenotypes is based on the following
model:
Yi = β0 +
∑
g
βg
(∑
k∈C
Xgik
)
+
∑
rs
γrs
 ∑
(j,k)∈C2
CrijC
s
ik
+ i. (4)
The difference with the first model concerns the simulation of the interaction
effect. In the second model the interaction effect for a causal couple (r, s) is
defined as the product of the first PCA component Cr.1 of gene r and the first
PCA component Cs.1 of gene s.
In both models, β0 is set to 0, and i are generated independently from
a N (0, σ2), with σ2 determined from the coefficient of determination R2 that
calibrates the strength of the association. Both simulation models can be written
as yi = XTi β +Z
T
i γ + i where X the marginal effect genotype matrix and Z
the interaction effect matrix.
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Let us denote Qφ = [X,Z]
β
γ
 and
R2 =
∑
(Qiφ− y¯)2∑
(Qiφ+ i − y¯)2
=
∑
(Qiφ− y¯)2∑
(Qiφ− y¯)2 +
∑
2i +
∑
2(i(Qiφ− y¯))
=
∑
(Qiφ− y¯)2∑
(Qiφ− y¯)2 + n vˆar(i) + 2n ˆcov(i,Qiφ− y¯) .
We remark that:
2n cov(i,Qiφ− y¯) = 2n cov(i,Qiφ−
∑
j yj
n
)
= 2n cov(i,Qiφ)−
∑
j
2n
n
cov(i, yj)
= 0− 2cov(i, i) = −2σ2
Thus, replacing vˆar(i) by σ2, and ˆcov(i,Qiφ − y¯) by −σ2/n, we obtain
R2 ≈
∑
(Qiφ− y¯)2∑
(Qiφ− y¯)2 + nσ2 − 2σ2 . This relation between R
2 and σ2 gives us an
expression for σ2 that depends on R2, σ2 =
(R2 − 1)∑(Qiφ− y¯)2
R2(2− n) .
We looked at how much of the coefficient of determination R2 is explained
by main effects, and how much is explained by interaction effects, in order to
determine their respective roles in the model.
For a similar reason, when simulating phenotypes, Wang et al. [17] examined
how much of partial R2 was due to interaction effects. They selected coefficient
values so that 30% of the partial R2 was explained by interaction effects. Li
and Cui [15] did not use the R2 directly, but they simulated data assuming
different proportions of interaction effects among the total genetic variance. In
our study, once the phenotype y had been set for each simulated design matrix,
we computed how much of the R2 could be attributed to interaction and main
effects as pI =
R2I
R2T
and pM =
R2M
R2T
respectively, with R2I the R-square value for
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the model containing only simulated interaction effects, R2M the R-square value
where there were only simulated main effects, and R2T R-square value where
there were both simulated main effects and simulated interaction effects.
Scenarios In the first (simplified) simulation study, genotypes are simulated
as described in the design. We considered six genes, each composed of six
SNPs and for 600 subjects. We define one causal interaction between genes and
two causal genes with main effects, and the simulation takes place using two
alternative simulation settings:
• (1) one interaction and two main effects involving the same genes
• (2) one interaction and two different main effects
For these two settings, different coefficients of determination, from 0.05 to 0.7,
are considered and 1000 iterations are performed.
In the second (realistic) simulation study, genotypes come from a real dataset
comprising 763 individuals. At each iteration we randomly select six genes of
various size (from 1 to 1119 with a median of 2 SNPs) in the dataset. We
consider the five following settings:
• (1) one interaction and two main effects involving the same genes
• (2) one interaction and two different main effects
• (3) one interaction effect only
• (4) two main effects only
• (5) no effects
For each setting, coefficients of determination, from 0.1 to 0.4, are considered
and 500 iterations are performed.
For both simulation studies, main effects and interaction effects are weighted
with the same coefficient values (βg = γrs = 2,∀g, r, s). For each interaction,
the power is estimated as the proportion of detected interactions over the total
number of simulations.
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Real data illustration
To illustrate our approach we applied the proposed method on three real datasets
related to ankylosing spondylitis, thyroid carcinomas and inflammatory bowel
disease.
The dataset regarding ankylosing spondylitis consists of the French sub-
set of the large study of the International Genetics of Ankylosing Spondylitis
(IGAS) study [22]. For this subset, unrelated cases were recruited through the
Rheumatology clinic of Ambroise Paré Hospital (Boulogne-Billancourt, France)
or through the national self-help patients’ association: "Association Française
des Spondylarthritiques". Population-matched unrelated controls were obtained
from the "Centre d’Etude du Polymorphisme Humain", or were recruited as
healthy spouses of cases. The protocol was reviewed and approved by the Ethics
committee of the Ambroise Paré hospital. All participants gave their informed
consent to the study. The application on thyroid carcinomas was carried out on
a public dataset that came from the study of Luzón-Toro el al. on identifica-
tion of epistatic interactions in two different types of thyroid carcinomas [23].
Finally, we used the Wellcome Trust Case-Control Consortium genome-wide
association dataset to study Inflammatory Bowel Disease.
Results
Simulation studies
In the following, we will refer to the different simulation settings by using letters
as described in Table 1.
Results from the simplified simulation study
Figure 1 shows results obtained for the two settings. The first column gives
the estimated power to detect the gene interaction as a function of the R2
values. The last two columns show heatmap matrices reflecting the proportion
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Table 1: Effects simulated in each settings and referring names according to the
phenotype simulation model
Settings Names
id Main effects Interaction effects Wang Pathway
model
PCA model
1 Genes 1 & 2 Genes 1 x 2 A B
2 Genes 1 & 2 Genes 3 x 4 C D
3 - Genes 1 x 2 E F
4 Genes 1 & 2 - OME
5 - - NE
of significant values for each variable and each method over the 1000 simulations
for different R2 values.
In the first setting (Figure 1(A,B)), we consider genes 1 and 2, both having
main and interaction effects. When the phenotype is simulated using the Wang
Pathway model, the G-GEE and PLS methods have a higher power to detect
the interaction effect than PCA method, which tends to identify only the two
main effects of the two genes (Figure 1(A)). Whereas for PCA and PLS the
power is nondecreasing with R2, for G-GEE we observe a U-shaped curve. For
the smallest R2 values, which correspond to the most difficult cases, the power
of G-GEE to detect the interaction tends to decrease. When R2 values reach
0.4, G-GEE’s power to detect the interaction starts to increase. The situation
is different for the main effects, since G-GEE’s power to detect these increases
continuously with R2 [see Additional file 1]. For PLS, the power to detect the
interaction effect is continuously nondecreasing. Note, however, that for this
method one of the two main effects (here gene 1) is detected to the detriment
of the second, regardless of the value of R2. In the PCA phenotype simulation
model (Figure 1(B)), G-GEE has a higher power than the other methods to
detect interaction effects while retaining a good specificity, whatever the value
of R2. The reasonably high power of the PCA method can be explained by the
similarity between the phenotype simulation model and the estimation model.
It is worth noting that in this first setting, only a few variables are falsely
significant, which reflects a good specificity for all methods (the worst being for
16
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Figure 1: Power and discoveries under a simplified context The figures
in the first column shows the power to detect interaction effects of the three
methods depending on the R2. The last two columns show the ratio of the
number of times where each variable was significant to the total number of
simulations for a given R2. The panels A, B, C and D refer to the different
simulation settings described in Table 1.
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the gene 3 × gene 4 interaction variable in the case of the Wang Pathway model
and r2 = 0.1, where the false discovery rate is 0.068).
In the second setting (Figure 1(C,D)), genes 1 and 2 have only main effects,
and genes 3 and 4 have only an interaction effect. When the phenotype is
simulated using the Wang Pathway model, the interaction power of G-GEE is
uniformly higher than that of the other methods (Figure 1(C)). For all values
of R2, PCA tends to detect false main effects for genes 3 and 4, but not to
detect interaction effects. In the PCA phenotype simulation (Figure 1(D)),
PCA has a good power to detect interaction effects, but once again these good
performances can be explained by the similarity between the simulation model
and the estimation model. The interaction power for G-GEE is lower, but still
good. With this model, only G-GEE tends to attribute a false main effect to
genes 3 and 4. In this second setting, whatever the phenotype simulation model,
the power of the PLS method is almost null. PLS identifies only the first gene
as having a main effect, while the effects of genes 3 and 4 are not detected,
whether as main or as interaction effects. Moreover, PLS tends to attribute a
false interaction effect between genes 1 and 2.
To evaluate the performances of the different methods in a more complex
context, we also consider a setting where we simulate 25 genes with four causal
interactions between genes, and two genes with causal main effects. In these
simulations, interaction genes are different from main effect genes, and we only
consider the case where R2 = 0.7. The results of this setting reflect the good
performance of the G-GEE method over PCA and PLS in detecting interaction
in a context where further interactions and different main effects are simulated
[see Additional file 2].
Results from the realistic simulation study
Figures 2 and 3 show results for the first three settings. Figure 2 shows the power
to detect gene interaction depending on the R2, and Figure 3 shows heatmaps
of significant effects when R2 = 0.2. In both figures, the upper row relates to
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phenotypes simulated using the Wang Pathway model, and the lower row to
phenotypes simulated using the PCA model.
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Figure 2: Power under a realistic context The figures show the power to
detect interaction effects of the three methods depending on R2. The panels A,
B, C, D, E and F refer to the different simulation settings described in Table
1.
In the first setting (Figure 2 (A, B), Figure 3 (A, B)), the same two genes
(genes 1 and 2) are simulated with main and interaction effects. In this setting
G-GEE has the best power to detect interaction effects for all R2 values. The
interaction power of PLS remains close to 0.3. The power of PCA depends on
the phenotype simulation model. When the phenotype is simulated using the
Wang Pathway model, the power is similar to PLS. When it is simulated using
PCA it increases continuously, because of the similarity between the phenotype
simulation model and the estimation model. Looking at the heatmaps (Figure 3
(A, B)) we can see that only a few variables are falsely significant. We also
observe that unlike G-GEE, PCA and PLS can detect the two simulated main
effects, with a preference for gene 1 in the case of PLS. These results are obtained
when R2 = 0.2, but other R2 values give similar results [see Additional file 3].
In the second setting (Figure 2 (C, D), Figure 3 (C, D)), main effects are
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Figure 3: Discoveries under a realistic context Heatmaps of the ratio of
the number of times where each variable was significant to the total number of
simulations for R2 = 0.2.The panels A, B, C, D, E and F refer to the different
simulation settings described in Table 1.
simulated for genes 1 and 2, and one interaction is simulated between genes 3
and 4. In this setting the power of PLS to detect interaction effects is almost
null, while the respective powers of PCA and G-GEE are different, according
to which phenotype simulation model is used. Both methods have a higher
power when the phenotype is simulated using the PCA model. Regarding the
detection of main effects, the results are similar to the first setting, with G-
GEE less successful than PCA and PLS (Figure 3 (C, D)). But unlike in the
first setting, here some variables are falsely significant. False detections among
interaction variables are more pronounced for G-GEE and concern genes that
have been simulated to have only main effects. False detections among main
effects are more pronounced for PCA and PLS when the phenotype is simulated
using the Wang Pathway model and concern genes that have been simulated to
have an interaction effect. Under the PCA phenotype model, false detections
among main effects are more pronounced for PLS and G-GEE when R2 values
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are higher [see Additional file 3].
In the third setting, where only one interaction is simulated between genes
1 and 2, G-GEE has a higher power to detect interaction than PLS and PCA
when the phenotype is simulated using the Wang Pathway model (Figure 2 E).
The power of PCA is higher in the PCA phenotype simulation model because
of its similarity to the estimation model, whereas the power of PLS is almost
null (Figure 2 F). In the Wang Pathway phenotype simulation model, PCA and
PLS both falsely detect main effects. In the PCA phenotype simulation model,
the false detections are made by PLS and G-GEE (Figure 3 (E, F)). In all cases
these false detections concern genes that are simulated to have an interaction
effect.
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Figure 4: Discoveries for the fifth and the sixth settings Heatmaps of
the ratio of the number of times where each variable was significant to the total
number of simulations for R2 = 0.4 when only main effects are simulated for
gene 1 and gene 2 (left), and when no effects are simulated (right).
Figure 4 shows the results for the fourth and fifth settings. The heatmap
on the left corresponds to the fourth setting, where only two main effects are
simulated. We remark that all methods successfully identify the main effect,
PCA and PLS doing so with a higher power. False detections corresponding
to the respective interaction effects are observed for G-GEE, and to a lesser
extent for PLS. The figure on the right corresponds to the fifth setting, where
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no specific effects are simulated and the result shows that all three methods
perform well with very few false detections.
In all settings, estimating the coefficients with the group lasso is more com-
putationally expensive than constructing the interaction variables. G-GEE and
PCA are quite similar in terms of computation time, whereas in some settings
PLS has a slightly greater execution time than other methods. Note that the
time required by G-GEE for constructing the interaction variables varies ac-
cording to the number of SNPs that constitute each gene [see Additional file
4].
Percentage of R2 attributable to interaction and main effects respec-
tively
Table 2: Average percentage of R2 attributable to interaction and main effects,
by setting, in the first simulation study.
A B C D
R2=0.7 R2=0.05 R2=0.7 R2=0.05 R2=0.6 R2=0.3 R2=0.7 R2=0.2
pI 97.73 92.08 33.11 32.80 33.32 33.47 33.51 33.57
pM 98.84 95.57 66.42 66.97 66.60 66.57 66.70 66.56
Using each setting in both simulation studies, we determine the pI and
pM average values that correspond to the proportion of the R2 attributed to
interaction and main effects, respectively. For most settings, the pI depends
on the number of simulated effects. With one interaction and two main effects
simulated the R2 part attributable to interaction effects is around 33% (Table 2
(B, C, D), Table 3 (C, D)). For the setting with numerous effects [see Additional
file 2], the average pI is 67% because we consider four interaction effects for
only two main effects. Finally, as expected, when only interaction effects are
Table 3: Average percentage of R2 attributable to interaction and main effects,
by setting, in the second simulation study.
A R2=0.2 B R2=0.2 C R2=0.2 D R2=0.2 E R2=0.2 F R2=0.2 OME R2=0.4
pI 94.01 52.04 33.36 33.27 100 100 0
pM 99.08 78.62 66.60 66.87 0 0 100
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simulated, the average pI is 100% (Table 3 (E, F)) and 0% when only main effects
are simulated (Table 3 (OME)). However, the R2 distribution between main and
interaction effects is not distinguishable in the setting where the phenotype is
simulated using the Wang Pathway model with the same main and interaction
effects. The pI and pM values are all above 90% (Table 2 (A), Table 3 (A)). In
the second simulation study, the R2 distribution is also not well divided between
main and interaction effects when the phenotype is simulated under the PCA
model, though pM is still higher than pI (Table 3 (B)).
Conclusions
The results obtained in both simulation studies point to a certain confusion
between main and interaction effects. When simulated interaction and main
effects involve different genes, the methods tend to detect as interaction effects
the pairs of genes simulated to have main effects and, conversely, to detect as
main effects the genes simulated to having interaction effects.
Overall, G-GEE tends to detect more false interactions than false main effect
whereas PLS and PCA tend to detect more false main effects though PLS tends
to attribute a false interaction effect between genes 1 and 2. This type of
confusion may explain the U-shaped power curve for G-GEE observed in the
first simulation study (Figure 1(A)). As the problem becomes harder, the genetic
effects of both genes are preferentially assigned to the interaction effect, implying
a better power to detect interaction where R2 values are small. Finally, we
remark that for G-GEE false detections of main effects are more frequent when
the PCA phenotype simulation model is used, whereas for the PLS and PCA
methods, where the number of false detections for main effects is higher when
the Wang Pathway phenotype simulation model is used.
Other observations regarding the power of the different methods can be
made with these simulation results. PLS has more trouble than PCA and G-
GEE in detecting interaction effects, and has a tendency to detect the first
main effect with a higher power than the second main effect when two main
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effects are simulated. For all methods, the power to detect interactions increases
more slowly with respect to R2 when simulations are performed using real data
genotypes than with fully simulated genotypes, but we observe that in the first
setting the curve representing the interaction power of G-GEE is detached from
the others, reflecting the superior performance of G-GEE over PLS and PCA.
Note that the power of G-GEE to detect main effects is always less than that
of PCA and PLS when R2 < 0.4 [see Additional file 1 and 5]. In short, G-GEE
performs better when detecting interactions than when detecting main effects.
Real data illustrations
Ankylosing spondylitis
Ankylosing spondylitis (AS) is a common form of inflammatory arthritis pre-
dominantly affecting the spine and pelvis. It occurs with a prevalence of 0.1%
to 1.4% depending on the considered population [24]. Genetic factors account
for more than 90% of the risk of susceptibility to AS. Human leukocyte antigen
(HLA) class I molecule HLA B27, belonging to the Major Histocompatibility
Complex (MHC) region, was the first genetic risk factor identified as associated
with ankylosing spondylitis in the 1970’s [25, 26] and remains the most impor-
tant risk locus for this pathology. Despite the strong association only a small
portion of HLA-B27 carriers develop the disease. Furthermore, studies in fam-
ilies suggest that less than 50% of the overall genetic risk is due to HLA-B27,
which suggests that other genetic factors are involved [27]. A number of updated
reviews on AS genetics, including genome-wide association study (GWAS) re-
sults, identified new ankylosing spondylitis-susceptibility genes outside of the
MHC region [28, 29].
We applied all the methods described above to the AS dataset. The data
contain 408 cases and 358 controls, and each individual was genotyped for 116,
513 SNPs with Immunochip technology. For each SNP we obtained detailed ge-
netic information, such as gene affiliation, with the NCBI2R package [30] which
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annotates lists of SNPs with current information from NCBI. We considered
only SNPs located within a single gene in order to form gene groups without
overlap. We focused our analysis on a list of 29 genes previously identified as
having a main effect in GWAS.
The three methods tested yield different results, and only the PLS and G-
GEE methods identify interactions. PCA detects only the main effect HLA-B
and identifies no interactions. PLS detects the main effect HLA-B, but also
identifies one interaction effect between the genes EOMES and BACH2. Our
method G-GEE does not detect any main effects, but it shows two significant
interactions, the first between the genes HLA-B and SULT1A1 and the second
between IL23R and ERAP2.
Thyroid carcinomas
Thyroid cancers are thought to be related to a number of environmental and
genetic predisposing factors and can be classified in various types and subtypes.
Most association studies have focused on main effects but only a limited num-
ber of genes were identified. Recently, some papers focus on the detection of
epistatic interactions [31, 23]. We applied our proposed approach on the two
data sets used in Luzón-Toro el al. [23] regarding two rare tumours, sporadic
medullary thyroid carcinoma (sMTC) and juvenile papillary thyroid carcinoma
(jPTC). Affymetrix Genome-Wide Human SNP 6.0 arrays were used to hy-
bridized DNA. The data set related to sMTC contains 66 cases and the jPTC
data set 30 cases. The same 125 healthy controls and 232, 607 SNPs were
used for both studies. As for the ankylosing spondylitis dataset, we obtained
gene affiliation for each SNP with the NCBI2R package and considered only
SNPs located within a single gene. We focused the analysis of the sMTC data
set on a list of 10 genes, 3 of these genes (CHFR, AC016582.2 and C8orf37)
were chosen following the conclusions of Luzón-Toro el al., the others because
they contained markers that were susceptible to be associated with the dis-
ease from univariate analysis. The analysis of the jPTC data set was realized
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on a list of 20 genes among them we can cite DIO, RP11-648K4.2, LOXL1,
DMGDH, PAX8 and STK17B from which epistatic interaction were already
detected (even if the interaction between PAX8 and STK17B was identified
in a study concerning papillary thyroid and not the juvenile form). The 14
others genes contained susceptible associated individual markers from univari-
ate analysis. Regarding the sMTC study, G-GEE identifies one interaction
between genes NCK1 and TRIQK. PCA detects only one main effect for the
gene TRIQK whereas none effects were identified with PLS. Concerning the
jPTC data set, 3 interactions were identified by G-GEE (NCAM1 and MNDA,
MNDA and STK17B, LOC105370481 and STX3). PLS identifies 2 interac-
tions (LOC105370236 and LOC105370481, LOC105370236 and PIKFYVE) and
PCA detects only one main effect for the gene LOC105370481. We note that
the effects detected with our approach concerned different genes that the ones
identified in the presented previous studies (except for the gene STK17B). More
analysese are needed to better understand these differences.
Inflammatory Bowel Disease
Although the etiology of Inflammatory Bowel Disease (IBD) is not completely
understood, previous studies have underlined the contribution of an important
genetic susceptibility. Recently, Martinez-Chamorro et al. [32] detected an
epistatic interaction between the genes NOD2 and TLR4. We applied our ap-
proach to the Wellcome Trust Case-Control Consortium genome-wide associa-
tion dataset for Inflammatory Bowel Disease. The data contains 1949 case for
159 960 SNPs genotyped by Affymetrix. The control group was constituted of
1972 individuals from the Wellcome Trust Case-Control Consortium genome-
wide association dataset for hypertension. As for the two previous real data
analysis, we obtained gene affiliation for each SNP with the NCBI2R package
and considered only SNPs located within a single gene. The analysis was real-
ized on a list of 22 genes that contain SNPs that are suspected to be associated
with IBD from an univariate analysis. The two genes NOD2 and TLR4 were
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added to the list as they were previously detected as having an epistatic in-
teraction. G-GEE identifies one interaction between the genes LOC105376008
and CACNB2 whereas PCA detects 9 main effects (IL23R, PODN, ATG16L1,
C5orf56, DNAH11, LOC105378282, HSD17B12, LINC00558, ADCY4) but none
interaction. Finally PLS identifies 3 main effects for the genes IL23R, PODN
and DNAH11 as well as 2 interactions the first one between the genes PODN
and FCRLA, the second one between PVT1 and NOD2.
Discussion
In this paper we compared different approaches for modelling gene-gene epista-
sis in a penalized regression framework. Our primary concern was the detection
of interaction effects, and for this purpose we defined a general model and tested
different interaction terms. We focused our analysis at the gene scale and com-
pared three ways to design the interaction term. Some methods were inspired
by previous proposed approaches based on dimensional reduction methods in-
cluding Principal Component Analysis (PCA) and Partial Least Square analysis
(PLS). We additionally proposed a new interaction modeling approach that we
called Gene-Gene Eigen-Epistasis (G-GEE), where one interaction variable is
built for each couple. The interaction variable was defined based on a criterion
that maximizes the covariance between the phenotype and the pairwise SNP
product matrix of the two genes. The interaction components were then intro-
duced in a Group Lasso penalized regression model that takes the gene structure
into account and is capable of handling a large number of genes simultaneously.
A power study of the different methods based on two different simulation
schemes (simplified and realistic) provided us with a rich body of information.
Across various papers in the literature we find comparisons of similar meth-
ods that use different phenotype simulation settings. In the present work we
compared two simulation models. Our first model was from a previous study
[17] that simulated the interaction component of each couple in an SNP pair-
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wise product fashion. Our second model defined the interaction component as
a pairwise product of representative variables of each gene. Overall the G-GEE
method performed well in detecting interactions in all the settings that were
tested, although it was not always able to do so in the settings where main and
interaction effects involved different genes. The power of the PCA method is
highly dependent on the phenotype simulation model, because of the similar-
ity between the second phenotype simulation model and the estimation model
of the PCA method. The PLS method is characterized by a lack of power in
detecting interactions. PLS performs well only when the related main effects
are also present. When the simulated main and interaction effects do not con-
cern the same genes, the detection capability of the PLS approach collapses
dramatically.
For all methods we observed a confusion phenomenon when active genes
are not simulated with both main and interaction effects. False detections of
interactions concern genes that were simulated to have main effects, and false
detections of main effects concern genes simulated to have interaction effects.
This phenomenon reveals the difficulty that all methods encounter in clearly
distinguishing the different types of effects. There are more false main detections
when using methods such as PCA and PLS that are better at detecting main
effects (except when the phenotype is simulated using the PCA model). As for
interaction effects, the G-GEE methods make more false interaction detections
than PCA and PLS.
When genotypes are fully simulated in the simplified simulation study, the
G-GEE and PCA approaches performed better when the PCA phenotype sim-
ulation model was used, whereas the PLS method was not very sensitive to the
choice of phenotype simulation model. Unlike PCA and PLS, G-GEE is better
at detecting interaction effects than at detecting main effects when simulations
use a real data set. Since the simulation study using realistic data is meant to
mimic real genotype data structure, we conclude that in a real context G-GEE
will be better at detecting interaction effects than main effects.
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In comparison to SNP-SNP interaction approaches, the gene-scale dimension
of our proposed method means that considerably fewer interaction variables need
to be considered within a genetic region. This reduction in problem size allows
larger problems to be handled. Moreover, a penalized regression method allows
a true multivariate approach over a larger number of genes. It also extends other
proposed gene-scale approaches, such as that presented by Wang et al. [8]. The
ability to handle a relatively large number of genes simultaneously makes the
detection of interactions between different genetic regions possible. This might
be useful as an initial step, prior to using SNP-SNP interaction methods that
may provide more accurate information.
As the G-GEE method is not able yet to consider all human genes at the
same time, it is necessary to specify a list of genes to be explored for potential
interactions. Given that its power to detect main effects is low, for the detection
of main effects it will be safer to use previously acquired knowledge of the genetic
effects, or to use a pre-processing method. Another limitation of the method is
gene size. Computing the gene Eigen-Epistasis vector for two genes of size pr
and ps requires an n× (prps) matrix to be computed.
Prospects are improving the G-GEE method’s performance by optimizing
the computational cost and exploring new interaction functions to be plugged
into the G-GEE criterion.
Availability of data and material: Our proposed G-GEE method has been
implemented in an R package which is available on github: https://github.com/vstanislas/GGEE
List of abbreviations used
• 3G-SPA: model-based kernel machine method
• AS: Ankylosing Spondylitis
• CCA: Canonical Correlation Analysis
• CCU: Canonical Correlation-based U-statistic model
• GGEE: Gene-Gene Eigen-Epistasis
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• GWAS: Genome-Wide Association Studies
• HLA: Human Leukocyte Antigen
• LD: Linkage Disequilibrium
• MAF: Minor Allele Frequency
• MHC: Major Histocompatibility Complex
• PC: Principal Components
• PCA: Principal Component Analysis
• PLS: Partial Least Squares
• SNP: Single-Nucleotide Polymorphism
Ethics (and consent to participate) The dataset regarding ankylosing
spondylitis consists of the French subset of the large study of the International
Genetics of Ankylosing Spondylitis (IGAS) study [22]. For this subset, unrelated
cases were recruited through the Rheumatology clinic of Ambroise Paré Hospital
(Boulogne-Billancourt, France) or through the national self-help patients’ asso-
ciation: "Association Française des Spondylarthritiques". Population-matched
unrelated controls were obtained from the "Centre d’Etude du Polymorphisme
Humain", or were recruited as healthy spouses of cases. The protocol was re-
viewed and approved by the Ethics committee of the Ambroise Paré hospital.
All participants gave their informed consent to the study.
The application on thyroid carcinomas was carried out on a public dataset
that came from the study of Luzón-Toro el al. on identification of epistatic
interactions in two different types of thyroid carcinomas [23]. This article is
distributed under the terms of the Creative Commons Attribution 4.0 Inter-
national License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction. All subjects underwent periph-
eral blood extraction for genomic DNA isolation using MagNA Pure LC system
(Roche, Indianapolis, IN) according to the manufacturer’s instructions. A writ-
ten informed consent was obtained from all the participants for clinical and
molecular genetic studies. The study was approved by the Ethics Committee
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for clinical research in the University Hospital Virgen del Rocío (Seville, Spain)
and complies with the tenets of the declaration of Helsinki.
Finally, the study on Inflammatory Bowel Diseases makes use of data gen-
erated by the Wellcome Trust Case-Control Consortium. A full list of the
investigators who contributed to the generation of the data is available from
www.wtccc.org.uk.
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Additional Files
Additional file 1 — Figure S1 Comparison of power to detect main effects
in the simplified simulation study.
Additional file 2 — Figure S2 Simulation on 25 genes with fully simulated
data and various simulated effects.
Additional file 3 — Figure S3 Discoveries in the realistic simulation study
with R2 = 0.4.
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Figure S1: Power under a simplified context The figures show the power
to detect main effects of the three methods depending on R2.
Additional file 4 — Figure S4 Comparison of execution time required to
model interaction and to fit Group Lasso for the five first settings of the realistic
simulation study.
Additional file 5 — Figure S5 Comparison of power to detect main effects
in the realistic simulation study.
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Figure S2: Discoveries for the setting with numerous effects Heatmap
of the ratio of the number of times where each variable was significant to the
total number of simulations for R2 = 0.7 using the Wang Pathway model for
the phenotype simulation with fully simulated data. We consider 25 genes with
two main effects for genes 1 and 2, and four interaction effects between genes 3
and 4, genes 5 and 6, genes 7 and 8, and genes 9 and 10.
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Figure S3: Discoveries under a realistic context Heatmaps of the ratio of
the number of times where each variable was significant to the total number of
simulations for R2 = 0.4.
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Figure S4: Execution time Median of the execution time to model interaction
and to fit Group Lasso for the five first settings of the realistic simulation study.
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Figure S5: Power under a realistic context The figures show the power to
detect main effects of the three methods depending on R2.
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